DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
17.38
+0.21 (1.22%)
Jul 29, 2025, 2:45 PM CST
SHA:603233 Market Cap
SHA:603233 has a market cap or net worth of 19.82 billion as of July 29, 2025. Its market cap has increased by 18.61% in one year.
Market Cap
19.82B
Enterprise Value
21.19B
Revenue
26.70B
Ranking
n/a
PE Ratio
20.18
Stock Price
17.38
Market Cap Chart
Since July 31, 2017, SHA:603233's market cap has increased from 14.24B to 19.82B, an increase of 39.15%. That is a compound annual growth rate of 4.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 29, 2025 | 19.82B | 15.54% |
Dec 31, 2024 | 17.15B | -39.52% |
Dec 29, 2023 | 28.36B | -24.55% |
Dec 30, 2022 | 37.59B | 12.85% |
Dec 31, 2021 | 33.31B | -35.46% |
Dec 31, 2020 | 51.60B | 89.92% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Jul 31, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 415.51B |
Shenzhen Mindray Bio-Medical Electronics | 280.36B |
WuXi AppTec | 278.17B |
Sichuan Biokin Pharmaceutical | 126.32B |
Zhangzhou Pientzehuang Pharmaceutical., | 121.87B |
Aier Eye Hospital Group | 121.31B |
Shanghai United Imaging Healthcare | 112.92B |
Yunnan Baiyao Group Co.,Ltd | 100.81B |